Clinical Trials Logo

Clinical Trial Summary

Spinal cord injury (SCI) is a devastating disability with physical, social and vocational consequences. Owing to its overwhelming complications, the cost of treatment and rehabilitation increases constantly. Persons with spinal cord injury are always dependent on their families in most of house hold, recreational and activities of daily life. Majority of SCI are incomplete classification C or D as per American spinal injury Association (ASIA). Due to certain spared pathways intrinsic mechanism of neuroplasticity take place in incomplete spinal cord injuries (iSCI) which is liable for natural recovery, but this potential is limited and often slow. Therefore there is need for some advance therapeutic interventions which may enhance neuroplasticity and improve functional recovery in individuals with iSCI. It has been reported that acute intermittent hypoxia (AIH) increase neuro plasticity by causing release of spinal serotonin which stimulate serotonin type 2 (5-HT2) receptors that undergoes a series of mechanisms which increase brain derived neurotrophic factors (BDNF) which subsequently enhance motor functions of upper and lower limbs in iSCI. Despite of the growing body of literatures supporting that AIH improves both upper limb and lower limb functions along with walking ability and speed. However, their results are limited to small sample size, gender biased and lack of intralimbs assessment. As per the author knowledge, these literatures lack retention effects of AIH on upper and lower limb function. In addition variables like quality of life, disability and some biomarkers related to hypoxic effects have not been reported in any of these studies. Furthermore, it is hypothesized that variant geographic locations and socioeconomic status may affects persons with iSCI differently. So in light of these literature gaps, the author aim is to investigate the effects of AIH in upper and lower limb motor function, balance, quality of life and disability. In addition, the effects of AIH on brain derived neurotrophic factors (BDNF), hemoglobin (Hb) level, numbers of RBS and hematocrits will be assessed.


Clinical Trial Description

Study design and setting: This will be Randomized Controlled Trail triple blind study design. The study will be conducted in Paraplegic center Peshawar (PCP) Pakistan https://paraplegiccenter.org/. Blinding of the participants: Patients 'selection and their allocation of treatments to experimental and control will be done by team of physiotherapists working in paraplegic center Peshawar whose will not the part of investigation team. Treatment will be given by trained physiotherapist within paraplegic center Peshawar while data will be analyzed by statistician working in Riphah international University Islamabad Pakistan. The investigators, patients and the treatment providers will be anonymous from the group allocation, treatment they receive and data analysis. Sampling Technique: Since the sample frame is available so sample technique will be Random Sampling by computer generated table of random number. Sample size: Sample size for the study calculated via G Power sample size calculator with power of 95% and α error probability is 0.05 on the following assumption. Walking speed (10MWT) post intervention in groups are: IH= 17.1±5.8 vs. Nx=7.1±2.8s. the effect was determined as 2.09. So the total sample size for both groups is 8 (4). Since this sample size is less so we consider our effect size 0.9 thus total sample size will be 68, each grip will be having 34 participants. Participants: Person with incomplete spinal cord injury will be our study participants. Tools/Outcome measures include the following 1. Hypoxico Hyp 123 2. Hand Dynamometer (Grip strength) Hydraulic guage (pinch strength) 3. Upper limb functional Test (9-Hole and Pegs Test, Box and Block Test) 4. Quick-DASH (Disability of arm, shoulder and hand) 5. Ten Minute Walk Test ,Time up and Go Test (walking performance) 6. Six Minute Walk Test(endurance) 7. Berg Balance Test (Balance) 8. WHO-QOL (BREF Urdu version) 9. Brain derived neurotrophic factors (BDNF) 10. Level of Hemoglobin, RBS and Hematocrits Interventions details: After randomly allocation of the patients into intervention and SHAM group. The Interventional group will be provided a brief sequence of mild hypoxia consisting of 9% oxygen for one minute followed by normoxia 21% of oxygen for a total of 15 episodes. The SHAM group' participants will be provided 21% of O2 (normoxia), comprised of 15 repetitions of 1-minute then switching to another 1-minute of 21% O2. Both these protocols will be provided 3 times/week for a period of 4 weeks. Both groups will continue their routine rehabilitation for the upper and lower limb exerccises within the center. Post assessments for the said variable will be carried out each week (post 7 days, post 14 days, post 21 days, post 30 days and a follow up week for retention effects). Data collection Procedure: After informed consent, all the willing and eligible participants will be randomly divided into intervention and SHAM group. Participant's demographic details will be taken which includes participant's age, geographic location, socioeconomic status, history of onset of iSCI, level of spinal cord injury, ASIA classification C/D and BMI. Outcome measure will be assessed as baseline at each week and after final as retention effect ass discussed above. Ethical consideration: Ethical consideration has been provided by the ethical board of Riphah International University Islamabad RIPHAH/RCRS/REC/Letter-0129 dated march 2022. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05491837
Study type Interventional
Source Riphah International University
Contact Ikram Ali, Master
Phone 00923343475727
Email drikramali@gmail.com
Status Not yet recruiting
Phase N/A
Start date January 1, 2023
Completion date September 4, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04102826 - Restoration of Arm Function in People With High-level Tetraplegia N/A
Recruiting NCT04052009 - Locomotor Training in Individuals With Incomplete Spinal Cord Injury. A Pilot Study N/A
Completed NCT01302522 - Mental Practice Impact on Gait and Cortical Organization in Spinal Cord Injury (SCI) Phase 2
Recruiting NCT05975606 - Non-invasive Brain Stimulation Paired With FES Cycling Post SCI N/A
Recruiting NCT04050696 - The Use of Electromagnetic Field (EMF) Treatment in Chronic Spinal Cord Injury (SCI) Patients N/A
Active, not recruiting NCT06079138 - Tele-rehabilitation Using tDCS Combined With Exercise in People With Spinal Cord Injury N/A
Recruiting NCT05605912 - Myosuit in Incomplete Spinal Cord Injury N/A
Recruiting NCT06214546 - Effect of Different Support Systems on Gait N/A
Completed NCT04340063 - Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury N/A
Recruiting NCT05142943 - Effectiveness of Virtual Bodily Illusion Intervention in Upper Limb Motor Function in People With Incomplete Spinal Cord Injury. N/A
Enrolling by invitation NCT05341466 - The Effect of Acute Intermittent Hypoxia on Motor Learning N/A
Completed NCT04910412 - Effects of tDCS With Gait Training on Leg Performance in Incomplete Spinal Cord Injury N/A
Recruiting NCT05726591 - Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders N/A
Recruiting NCT03057652 - Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait Training N/A
Recruiting NCT05429736 - Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity N/A
Completed NCT01851629 - Walking Adaptability Post-Spinal Cord Injury N/A
Recruiting NCT01961557 - Evaluating a New Knee-Ankle-Foot Brace to Improve Gait in Children With Movement Disorders N/A
Recruiting NCT04977037 - A Telerehabilitation Program for SCI N/A
Active, not recruiting NCT04809987 - Effectiveness of Virtual Gait System Intervention in Motor Function in People With Incomplete Spinal Cord Injury. N/A
Not yet recruiting NCT06169657 - Comparison of Gait Training Methods in Sub-acute Stroke and Spinal Cord Injury